乳腺癌细胞中下调RABEX-5对其化疗敏感性的影响
The Effect of RABEX-5 Downregulation on the Chemosensitivity of Human Breast Cancer Cells
-
摘要: 目的 探讨RABEX-5下调表达后,乳腺癌细胞对蒽环类药物和紫杉类药物的敏感性变化。方法 构建RABEX-5 RNAi慢病毒表达载体,并感染人乳腺癌细胞株MCF-7,使细胞内RABEX-5基因表达沉默, Real-time PCR、Western blot方法检测沉默效应。应用CCK-8方法检测RABEX-5沉默后(MCF-7/RNAi),与其阴性对照人乳腺癌细胞株(MCF-7/vector)相比对化疗药物敏感性的变化情况。结果 RABEX-5 RNAi慢病毒表达载体感染MCF-7后,与未干扰组(MCF-7)及阴性对照组(MCF-7/vector)相比,RABEX-5的mRNA和蛋白水平表达下调。与阴性对照组相比,RABEX-5下调表达后,对蒽环类药物表柔比星的化疗敏感性降低,半数致死浓度(IC50)分别为(3.590 0±0.228 69) μg/mL、(1.193 3±0.187 71) μg/mL,差异有统计学意义(P50)分别为(11.162 7±0.210 26) μg/mL、(10.536 7±0.430 97) μg/mL,差异无统计学意义(P>0.05)。结论 RABEX-5下调表达使人乳腺癌细胞MCF-7对蒽环类药物表柔比星产生耐药,而对紫杉类药物多西他赛敏感,为进一步研究RABEX-5在乳腺癌个体化治疗中的作用提供理论基础。Abstract: Objective To investigate the changes in sensitivity to anthracycline and taxanes of human breast cancer cells after RABEX-5 downregulated. Methods By constructing a lentiviral vector for RNA interference (RNAi) of RABEX-5 gene and transfected into human breast cancer cell line MCF-7 to silence the express of RABEX-5. Real-time PCR and Western blot were used to detect the silencing effect. The changes in sensitivity to chemotherapeutic drugs of MCF-7/RNAi and its negative control cell lines MCF-7/vector were detected by CCK-8 reagent. Results Compared with MCF-7 cell and MCF-7/vector cell, the expression of RABEX-5 mRNA and protein was downregulated in MCF-7/RNAi cells. The sensitivity to epirubicin was reduced after downregulating the expression of RABEX-5, the 50% inhibition concentration (IC50) of MCF-7/RNAi 〔(3.590 0±0.228 69) μg/mL〕 was higher than that of MCF-7/Vvector 〔(1.193 3±0.187 71) μg/mL, P50 were (11.162 7±0.210 26) μg/mL and (10.536 7±0.430 97) μg/mL, respectively (P>0.05). Conclusion Downregulation of RABEX-5 can induce chemoresistance to epirubicin in human breast cancer cell MCF-7; while its effect on sensitivity to docetaxel is not significant. This study can provide a theoretical basis for future research RABEX-5 in the individualized treatment of breast cancer.
© 2013 《koko体育app
学报(医学版)》编辑部 版权所有
开放获取♔ 本文遵循知识共享署名—非商业性使用4.0国际许可协议(CC BY-NC 4.0),允许第三方对本刊发表的论文自由共享(即在任何媒介以任何形式复制、发行原文)、演绎(即修改、转换或以原文为基础进行创作),必须给出适当的署名,提供指向本文许可协议的链接,同时标明是否对原文作了修改;不得将本文用于商业目的。CC BY-NC 4.0许可协议详情请访问